Clinical Trials

October 01, 2024

Understanding CAR T-Cell Therapy and the Armored CAR T-Cell Trial

September 30, 2024

Learn about clinical trials to open the door to accessing innovative cancer treatments.

September 06, 2024

Learn how BTK degrader BGB-16673 can aid in managing CLL/SLL if you've previously taken BTK inhibitors and venetoclax.

August 23, 2024

Learn how zanubrutinib and venetoclax helped high-risk CLL patients with del(17p)/TP53 mutation as their first treatment from the SEQUOIA study.

July 17, 2024

Learn about cem-cel, a CAR T-cell therapy made from donor T-cells that may decrease T-cell exhaustion and is more quickly available than liso-cel (Breyanzi).

April 17, 2024

Dr. Inhye Ahn is conducting a clinical trial utilizing pirtobrutinib combined with obinutuzumab for CLL patients needing treatment for the first time.

April 15, 2024

Dr. Inhye Ahn from Dana-Farber Cancer Institute is conducting a clinical trial that administers a personalized vaccine for CLL called NeoVax. 

April 10, 2024

Learn about BTK degraders, a new type of CLL medicine in clinical trials that help overcome treatment resistance.

March 25, 2024

Learn about how the medicine Epkinly is helping high-risk CLL patients inside of a clinical trial.

May 31, 2023

Dr. Gunjan L. Shah and her team at MSK in NY are conducting a clinical trial to reverse T-cell exhaustion by pairing antioxidants alongside CAR T-cell therapy.